Freeze-Killed M2 Macrophage-Encapsulated MXene Nanocomposites for Multifunctional Photothermal Therapy in Diabetic Wound Healing Authors: Kaiyuan Chen, Hao Jiang, Yining Geng, Meichen Song, Yuxin Han, Sen Liu, Xingjiang Li, Xiaohuan Yuan, Jie Gao, Yan Wu Published: 2026 ABSTRACT AbstractIntroductionDiabetic wound healing remains a significant clinical challenge because of persistent inflammation, excessive oxidative stress, and bacterial infection. This study aimed to develop a biomimetic nanocomposite with multifunctional properties of antioxidation, antibacterial activity, anti-inflammation, and pro-angiogenesis for photothermal synergistic repair of diabetic wounds.MethodsFreeze-killed M2 macrophages were used to encapsulate MXene nanoparticles to prepare a biomimetic composite material (abbreviated as MM). Its structural characteristics, protein retention, and photothermal performance were characterized and analyzed. The anti-inflammatory, antioxidant, antibacterial, and pro-angiogenic abilities of the material were evaluated in vitro. A streptozotocin (STZ)-induced diabetic mouse wound model was established to systematically assess the effects of MM combined with near-infrared light (NIR) on wound healing, collagen deposition, and in vivo inflammation regulation.ResultsMM successfully preserved the cellular structure and functional proteins of M2 macrophages and exhibited excellent photothermal conversion performance. In vitro, it significantly inhibited pro-inflammatory cytokine secretion, scavenged reactive oxygen species, efficiently eliminated Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), and effectively promoted angiogenesis. In vivo experiments demonstrated that MM combined with NIR irradiation accelerated diabetic wound closure, enhanced collagen deposition, and induced macrophage polarization toward the anti-inflammatory M2 phenotype, with favorable biocompatibility and no obvious toxicity at the experimental dose.DiscussionFreeze-killed M2 macrophage-encapsulated MXene nanocomposites can synergistically modulate the three key pathological hallmarks of diabetic wounds: persistent inflammation, oxidative stress, and bacterial infection. Triggered by NIR, they exert potent reparative effects, offering a safe, multifunctional, and translationally promising therapeutic strategy for chronic diabetic wounds.Keywords: MXene, diabetic wound healing, photothermal therapy, antioxidant activity, anti-inflammation, macrophage corpse, biomimetic biomaterials Introduction Diabetic wounds represent one of the most severe complications associated with diabetes.1 In hyperglycemic conditions, the body generates an excessive quantity of reactive oxygen species (ROS), leading to oxidative stress and subsequent disruption of the wound microenvironment. This pathological state keeps the wound in an inflammatory state for a long time, and inflammation further accelerates ROS production. Moreover, chronic wounds are prone to secondary bacterial infections, which further hinder wound healing. These pathological processes interact with each other, forming a vicious cycle that results in persistent nonhealing of the wound; in severe cases, the condition may progress, ultimately requiring amputation surgery. Conventional therapeutic approaches for managing diabetic wounds encompass glycemic regulation, wound debridement, and various types of dressings. For stubborn wounds, negative pressure wound therapy, local growth factor therapy, hyperbaric oxygen therapy, and other treatment methods are available.2–5 However, such methods still face notable limitations in clinical application. For instance, some protocols possess relatively limited functional capabilities, making them inadequate for addressing the multifaceted requirements of wound repair. Moreover, therapeutic outcomes are often compromised by factors such as patient-specific variability and the complex wound microenvironment, resulting in suboptimal efficacy that has yet to reach the desired clinical standard.2–5 Therefore, it is imperative to develop a novel class of biomaterials that exhibits antioxidant, anti-inflammatory, and antibacterial capabilities to modulate the local microenvironment of diabetic wounds and enhance the wound healing process. With continuous advancements in biomaterial science, numerous biomimetic composite nanobiomaterials have been increasingly utilized.6–9 These materials can fulfill diverse requirements for wound repair through structural biomimicry, functional biomimicry, and intelligent responsiveness, interrupting the vicious cycle of adverse pathological conditions and enabling effective therapeutic outcomes for diabetic wounds.10–12 To address the critical needs for multifunctional agents that integrate antioxidation, anti-inflammation, and antibacterial capabilities—key requirements for reversing the pathological microenvironment of diabetic wounds—MXene has been identified as a highly promising candidate for investigation in our study. Owing to its unique physicochemical properties (e.g, excellent redox activity, broad-spectrum antibacterial efficacy, and tunable surface chemistry), MXene inherently aligns with the multifunctional demands of diabetic wound repair, making it an ideal material of choice to underpin our therapeutic design. MXene, first discovered in 2011 by Yury Gogotsi and Michel Barsoum, who are professors from Drexel University in the United States, is a type of two-dimensional nanomaterial characterized by a graphene-like structure, consisting of transition metal carbides, nitrides, or carbon nitrides, with a general formula Mn+1Xn.13–15 MXene, through its unique functional groups, can eliminate free radicals in the body and alleviate oxidative stress damage, thereby protecting cells and tissues.16 MXene also displays efficient photothermal conversion upon light irradiation, transducing optical energy into localized heat. This property gives it great potential to kill tumors and resist bacterial infections. The photothermal effect of antibacterial agents differs from that of antibiotics; antibacterial agents do not cause bacteria to develop resistance and can effectively prevent antibiotic failure.17 Emerging photothermal antibacterial technology has broad application potential. Multiple experimental studies have confirmed the effectiveness of photothermal technology in the field of antibacterial activity.1,18–20 However, as an exotic nanomaterial, MXene is readily identified and subsequently cleared by the body’s immune system, thus preventing it from fully exerting its functions. Recently, cell-based drug delivery systems have been extensively utilized because of their unique advantages.21,22 Cell carriers have high specificity and long persistence, while the cell membrane has a complex mechanism to avoid immune system attacks. Using cells to synthesize relevant nanomaterials ensures high biocompatibility, enhances the targeting efficacy of drug delivery, and prevents rapid degradation in vivo.23 Cell membranes, cell-derived nanovesicles, and exosomes have been used to encapsulate nanoparticles or drugs, thereby achieving efficient drug delivery.22,24 In addition, living and dead cells are also used as drug carriers because of their natural physiological functions to precisely deliver drugs to the lesion site. This strategy augments drug effectiveness with concomitant reduction of systemic toxicity.25,26 Using living cells requires strict control of cell sources and quality, which is costly, difficult to preserve, and prone to immune responses because of immunogenicity; thus, their use has significant limitations. However, using dead cells (cell corpses) can avoid these limitations.25,27–29 Compared with their living counterparts, cell corpses exhibit distinct advantages, including the absence of proliferative potential, enhanced biocompatibility and safety profile, reduced manufacturing costs, facile preservation and transportation, and diminished immunogenicity, which collectively broaden their applicability in biomedical scenarios.25,27–29 Macrophages are integral to the regulation of both innate and adaptive immune responses, the maintenance of homeostasis, and the protection of the organism.24,30,31 The membrane surface of these cells is characterized by the presence of specific proteins, including cell adhesion molecules such as integrins and selectins, as well as chemokine receptors, the latter of which have the capacity to bind to specific adhesion molecules and inflammatory chemokines. These ligands are markedly upregulated in inflammatory endothelial cells to facilitate transendothelial migration,32 and the secretion of inflammatory mediators may contribute to resistance against foreign invasion.27,28 In this study, a biomimetic composite nanomaterial (macrophage-corpse-coated MXene, MM) was successfully synthesized to promote wound healing in diabetic mice. This material innovatively uses M2-type macrophages to impart anti-inflammatory functions to MM while leveraging the natural cell membrane structure of macrophage corpses to effectively circumvent opsonization and phagocytosis by host immune surveillance. MXene, with its unique physical structure and excellent photothermal properties, synergistically performs antioxidant and antibacterial functions. MM, a novel multifunctional biomimetic nanocomposite, possesses therapeutic properties, encompassing anti-inflammatory, antioxidant, and antibacterial effects. Thus, this work presents a novel therapeutic paradigm for diabetic wound healing and broadens the application prospects of biomimetic nanomaterials. Materials and Methods Materials MXene (BK2020040305, thickness: 0.3–5 nm) was obtained from Beike Nano Technology Co., Ltd. (Suzhou, China). NIH-3T3 fibroblasts and RAW 264.7 macrophages were purchased from Enzyme Research Biotechnology Co., Ltd. (Shanghai, China), and human umbilical vein endothelial cells (HUVECs) were acquired from Cyagen Biosciences Co., Ltd. (Shanghai, China). E. coli and S. aureus were sourced from Fenghui Biotechnology Co., Ltd. (Hunan, China). Fetal bovine serum (2064652) and DMEM (C11995500BT) were procured from Gibco Co., Ltd. (United States). 0.25% trypsin-EDTA solution (CO201) was obtained from Beyotime Biotechnology Co., Ltd. (Shanghai, China). Agarose powder and MTT were purchased from Biofroxx Co., Ltd. (Germany). Streptozotocin, 5 × loading buffer, hematoxylin, eosin, and modified Masson’s trichrome staining kits were obtained from Solarbio Science and Technology Co., Ltd. (Beijing, China). DAPI, Hoechst 33342, and a ROS detection kit were purchased from Beyotime Biotechnology Co.,Ltd (Shanghai, China). Peptone and yeast extracts were obtained from Oxoid Co., Ltd. (UK). The total DNA extraction kit was sourced from Omega Bio-Tek Co., Ltd. (United States). Antibodies against cluster of differentiation (CD86), cluster of differentiation (CD206), and α-smooth muscle actin (α-SMA) were purchased from Affinity Biosciences Co., Ltd. (United States). A goat anti-rabbit immunoglobulin G (IgG) antibody conjugated with horseradish peroxidase was procured from Zhongshan Golden Bridge Biotechnology Co., Ltd. (Beijing, China). ICR mice (male, 7–8 weeks old, 22–25 g) were purchased from and housed in the Comparative Medicine Center of Mudanjiang Medical University (Production license number: SCXK 2024-003). The housing conditions were as follows: temperature (22±2) °C, relative humidity (50±10)%, 12-hour light-dark cycle, and free access to food and water. The animal experimental protocols used in this study were reviewed and approved by the Animal Ethics Committee of Mudanjiang Medical University (Certificate No. 20240716-030) and complied with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Determination of the Optimal IL-4 Concentration for M2 Macrophage Polarization In a six-well plate, 2×105 cells were seeded in each well. After 12 hours, different concentrations of IL-4 (20, 40, and 80 ng/mL) were administered to each well, and the cells were subsequently incubated for 24 hours. Afterward, the expression levels of genes were quantified using reverse transcription quantitative polymerase chain reaction (RT-qPCR). First, the cells underwent a washing procedure with phosphate-buffered saline (PBS). Subsequently, ribonucleic acid (RNA) was isolated using an RNA extraction kit (Beyotime). The concentration of total RNA was then determined using a nucleic acid and protein analyzer. Reverse transcription was subsequently performed using a reverse transcription kit (Xinbei) by a two-step method, and finally, the detection program was run on a 96-well fluorescence quantitative PCR instrument. Synthesis of MM The macrophages were cultured in DMEM supplemented with 10% fetal bovine serum (FBS) to achieve a cell density of 5×106 cells. Subsequently, they were stimulated with 20 ng/mL interleukin-4 (IL-4) for 24 hours to differentiate into M2-type macrophages (the IL-4 concentration was determined in preliminary experiments, Figure S1). MXene was subsequently cocultured with these M2 macrophages at a concentration of 100 μg/mL for 24 hours. Subsequent to collection, the cells underwent centrifugation at 1000 revolutions per minute for 3 minutes, following which the supernatant was meticulously decanted. The precipitate was redispersed in 1 mL of PBS, transferred to a cryotube, and directly immersed in liquid nitrogen for 24 hours to prepare the final material—MXene nanoparticles encapsulated with macrophage corpses (hereafter referred to as MM). M2 macrophage corpses (hereafter referred to as M2) were prepared similarly to the aforementioned MM, excluding the coculture step with MXene. Briefly, M2-type macrophages were collected directly and subjected to centrifugation at 1000 revolutions per minute for 3 minutes. Subsequently, the supernatant was meticulously decanted, and the resultant cell pellet was redispersed in 1 mL of PBS, transferred to a cryotube, and frozen in liquid nitrogen for 24 hours. For subsequent experiments, M2 and MM were retrieved from liquid nitrogen and immediately thawed in a 37°C water bath until completely melted. Measurement of MM Cell Viability The viability of MM was detected using a live/dead cell staining kit, with live M2-type macrophages serving as controls. Live M2-type macrophages were seeded at 1×105 cells/well in glass-bottomed cell culture dishes and cultured for 24 hours. Subsequently, the culture medium was discarded, and the cells were carefully rinsed twice with PBS. The MM samples were subsequently subjected to centrifugation at 1000 revolutions per minute for 3 minutes, following which the supernatant was carefully removed. Both groups were subsequently incubated with 200 μL of live/dead cell staining working solution at 37°C in a cell incubator for 30 minutes, after which images were acquired via laser confocal microscopy, and the numbers of live and dead cells were quantified using ImageJ software. Analysis of the Cytoskeleton Staining of MM The cytoskeletal integrity of MM was assessed via phalloidin staining, with live M2-type macrophages serving as controls. Live M2-type macrophages were plated onto glass-bottomed wells (1×105 cells/well) and maintained in culture for 24 hours, after which the cytoskeleton was stained following the manufacturer’s protocol. For MM samples, centrifugation was performed at 1000 rpm for 3 minutes. Subsequently, the supernatant was decanted, and the resultant precipitate was redispersed in 200 μL of phalloidin green fluorescent probe staining solution. Both groups were subsequently counterstained with 1 μL of DAPI staining solution, underwent incubation at 37°C within a cell incubator for 30 minutes, and imaged via laser confocal microscopy. The diameters of the live and dead cells were quantified using ImageJ software. Protein Characterization of MM Using Coomassie Brilliant Blue and Western Blotting The protein profiles of live M2-type macrophages, M2, and MM were analyzed via Coomassie Brilliant Blue staining, and the expression of anti-inflammatory and vascular factors in MM cells was quantified by immunoblotting. Briefly, proteins were extracted from live M2-type macrophages, M2, and MM with RIPA lysis buffer supplemented with 1% protease inhibitor. Following the determination of protein concentration using a microplate assay, the samples were combined with loading buffer, subjected to denaturation at 95°C for 10 minutes, and subsequently stored at 4°C. SDS-PAGE was conducted, and the resulting gel was subsequently stained using Coomassie Brilliant Blue with a rapid staining solution for 30 minutes and captured using a digital camera. For immunoblotting, proteins separated by SDS-PAGE were transferred to PVDF membranes, blocked with 5% skim milk for 1 hour, and incubated with primary antibodies against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (internal reference), CD206, IL-4, ARG-1, and CD86 (1:1000) at 4°C overnight. Following washing with TBST, the membranes were incubated with a horseradish peroxidase-conjugated secondary antibody at a dilution of 1:10,000 for 2 hours and then thoroughly washed. Bands were developed using an A600 imaging system and quantified via ImageJ software. Analysis of MM Surface Microstructure Using Scanning Electron Microscopy (SEM) Live M2-type macrophages and MM were collected and subsequently centrifuged at 1000 revolutions per minute for 3 minutes. Subsequently, the supernatant was carefully removed and discarded. After fixation with 1 mL of 2.5% glutaraldehyde (room temperature for 30 minutes, then 4°C for 12 hours), the samples underwent a triple rinsing process with 0.1 mol/L PBS, with each rinse lasting 15 minutes to remove residual fixative. For dehydration-free SEM sample preparation, samples were rapidly frozen in liquid nitrogen, transferred to a cryo-SEM ultrahigh vacuum cryostage, and sputter-coated with a thin platinum layer via vacuum sputtering. The microscopic morphologies were examined using cryo-SEM at an appropriate accelerating voltage. Transmission Electron Microscopy (TEM) to Ascertain the Cross-Sectional Microscopic Morphology of the MM Live M2-type macrophages and MM were mixed with cryo-embedding medium at an appropriate ratio and incubated at 37°C for 12 hours. Subsequently, the mixture was pipetted into an embedding mold and polymerized in a 60°C oven for 48 hours to form a rigid embedding block. For dehydration-free ultrathin sectioning, the embedding block was first cooled to cryogenic temperatures using liquid nitrogen to maintain the cells’ native hydrated state. Ultrathin sections were prepared using an ultramicrotome fitted with a diamond knife and subsequently collected onto copper grids. These sections underwent sequential staining with 2% aqueous uranyl acetate for 30 minutes, followed by lead citrate for 15 minutes, to enhance structural contrast. This staining process was succeeded by three rinses with distilled water and air-drying. The stained copper grids were mounted on a TEM sample stage and observed under an accelerating voltage ranging from 80 to 120 kV. Representative ultrastructural images were captured. Detection of the Zeta Potential of MM by a Malvern Particle Size Analyzer The Zeta potentials of M2 and MM suspensions were determined using a Malvern particle size analyzer. The M2 and MM suspensions were added to a Zeta potential-specific colorimetric cuvette respectively. The detection temperature was set at 25°C, and the equilibrium time was 60 seconds. Each sample was automatically measured three times. Detection of MXene in MM by Ultraviolet-Visible (UV-Vis) Spectrophotometry The absorption characteristics of MXene and MM were determined by UV-Vis spectrophotometry. 2 mL of MXene dispersion at various concentrations and 2 mL of MM suspension (100 μg/mL) were added to a 1 cm quartz cuvette respectively. A corresponding volume of PBS buffer solution served as the reference standard. Full-wavelength scanning was performed using a dual-beam spectrophotometer across the 200–500 nm range, employing a scanning interval of 1 nm and a bandwidth of 2 nm. To mitigate systematic errors, each experimental procedure was conducted in triplicate, and the resulting data were averaged to determine the absorbance within the specified wavelength range. Photothermal Performance Test of MM MXene solution and MM suspension were added to 200 μL centrifuge tubes respectively, and subsequently subjected to NIR irradiation for 5 minutes. Temperature variations were systematically observed in real-time using a thermal infrared camera, with thermal images being recorded at consistent intervals. The temperature changes of MXene solution and MM were also detected under five photothermal-cooling cycles. In vitro Anti-Inflammatory Performance Test of MM The anti-inflammatory effect of MM was evaluated in vitro using RT-qPCR. The experiment was divided into 7 groups: negative control group (Control), positive control group (M1), M2 group (M2), MXene group (M), MXene with NIR group (ML), MM group (MM), and MM with NIR group (MML). The ML and MML groups were exposed to NIR irradiation at a wavelength of 808 nm and an intensity of 1 W/cm2 for 5 minutes. All groups were subsequently followed by an additional incubation period of 24 hours in a cell incubator maintained at 37°C. After the treatments were completed, gene expression was detected by RT-qPCR. Briefly, the cells underwent washing with PBS, followed by the extraction of total RNA using an RNA extraction kit (Beyotime). Extracted RNA concentration was quantified via a nucleic acid and protein analyzer. Finally, a two-step reverse transcription process was conducted employing a reverse transcription kit (New-Bio). The assay protocol was then executed on a 96-well fluorescence quantitative PCR instrument. In vitro Antioxidant Performance Test of MM NIH-3T3 fibroblasts were plated into 96-well plates at 5×103 cells/well and cultured for a period of 24 hours. Thereafter, hydrogen peroxide solutions at concentrations of 0, 300, 400, 500, 600, 700, 800, 900, and 1000 μmol/mL were administered to each experimental group, followed by a further 24 hours incubation. Cell viability was measured using the MTT method. The concentration of H2O2 required to reduce cell viability to 50% was determined. NIH-3T3 fibroblasts were plated into 6-well plates at 3×105 cells/well and incubated for 24 hours. The test included 7 groups: the negative control group (Control), H2O2 positive group (ROS), M2 group (M2), MXene group (M), MXene with NIR group (ML), MM group (MM), and MM with NIR group (MML). The Control group was constituted by adding 500 μL of complete culture medium, whereas the H2O2 group was constituted by adding 500 μL of complete medium supplemented with 600 μmol/L H2O2 (the H2O2 concentration was determined in our preliminary experiments, Figure S2). For the other treatment groups, the MXene group was established by adding 500 μL of complete medium containing both 600 μmol/L H2O2 and 100 μg/mL MXene. M2 and MM cell precipitates were reconstituted in 500 μL of complete medium containing 600 μmol/L H2O2. The ML and MML groups underwent exposure to NIR irradiation at a wavelength of 808 nm and an intensity of 1 W/cm2 for 5 minutes. Subsequently, the cells were incubated at 37°C for an additional 12 hours. Post-incubation, the cells were washed with PBS and then maintained in a serum-free medium containing 10 μmol/L 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) for 30 minutes, and washed three times with serum-free medium, after which they were stained with 1 μL of Hoechst 33342 for nuclear counterstaining. The intracellular levels of ROS were assessed using a fluorescence microscope. In vitro Antibacterial Properties of MM The antibacterial performance of MM was detected using the plate colony counting method. The test included 8 groups: the control without NIR group (Control, NIR-), control with NIR group (Control, NIR+), M2 group (M2, NIR-), M2 with NIR group (M2, NIR+), MXene group (M, NIR-), MXene with NIR group (M, NIR+), MM group (MM, NIR-), and MM with NIR group (MM, NIR+). The E. coli and S. aureus bacterial suspensions were standardized to 1×106 CFU/mL. Then, M2, MXene, and MM were added to the bacterial culture medium (sterile PBS solution was introduced to the Control group). The NIR groups were subjected to NIR irradiation with 808 nm wavelength light at an intensity of 1 W/cm2 for 5 minutes. Following the preparation of the bacterial suspension, the mixture underwent a 1000-fold dilution and was maintained at room temperature for 30 minutes. Subsequently, 20 μL of the bacterial suspension was uniformly distributed on a Luria-Bertani (LB) agar plate using a spreader. The plates were then incubated in a controlled-temperature incubator set at 37°C. Following an incubation period of 18 to 24 hours, images were captured, and the quantity of colonies formed on the agar plates was quantified using ImageJ software. Angiogenesis Assay The test included 6 groups: the Control group (Control), M2 group (M2), MXene group (M), MXene with NIR group (ML), MM group (MM), and MM with NIR group (MML). In precooled 96-well plates, 50 μL of the matrix gel was introduced into each well and subsequently incubated at 37°C for 1 hour. After the matrix gel solidified, a mixture of 3×104 endothelial cells and the material was transferred to each well and incubated for 3 hours. The ML and MML groups were exposed to NIR irradiation at a wavelength of 808 nm and an intensity of 1 W/cm2 for 5 minutes. Finally, pictures were taken using an inverted microscope. Tube formation was analyzed using ImageJ software. Creation of a Diabetes Wound Model Male ICR mice underwent a fasting period of 12 to 16 hours prior to receiving an intraperitoneal injection of streptozotocin (STZ) at a dosage of 100 mg/kg on the first day, followed by a dosage of 50 mg/kg on the second and third days. Normal feeding resumed afterward. Body weight and water intake of mice were recorded every 3 days. Two weeks later, diabetic mice with a random blood glucose concentration ≥16.7 mmol/L were considered to have been successfully generated. The mice were anesthetized using pentobarbital sodium at a dosage of 50 mg/kg. Subsequently, the dorsal fur was shaved, and two full-thickness skin defects (6 mm in diameter) were created using a circular punch. They were randomly divided into 6 groups (the names of the groups were the same as those of the above experiments): Control (subcutaneous injection of 200 μL of PBS), M2 (200 μL of M2 cell suspension), and M, MM, ML, and MML groups (200 μL of suspensions with a 100 μg/mL equivalent MXene concentration). The experimental groups designated for light exposure were subjected to irradiation using an 808 nm laser at an intensity of 1 W/cm2 for 5 minutes, commencing immediately following the injection procedure. The treatment was continued for 3 days. Digital cameras were used to take pictures of the wound surfaces of diabetic mice on days 0, 3, 6, 9, and 12. The wound healing conditions were observed, and the wound healing rate was determined using the following formula: Wound healing rate (%) = (A0 - At)/A0 × 100%. A0 was the original area of the wound, and At was the area of the wound on days 3, 6, 9, and 12. Histological Analysis of Regenerating Skin Tissue To observe the pathological alterations in histogenesis and collagen deposition across various stages of the regenerative process, both hematoxylin-eosin (H&E) staining and Masson’s trichrome staining were employed. On days 6 and 12, following euthanasia of the mice using sodium pentobarbital, wound healing samples were retrieved and immediately immersed in 4% paraformaldehyde. The samples were dehydrated, infiltrated with paraffin, embedded, sectioned into 5-μm slices, and then affixed to glass slides for staining. H&E and Masson’s trichrome staining procedures were executed in accordance with the guidelines provided by the manufacturer. Then, the slides were sealed, and images were collected for subsequent analysis. For the immunohistochemical analysis, paraffin sections were subjected to a blocking step using 3% bovine serum albumin (BSA) for 1 hour. Subsequently, the sections were incubated with primary antibodies targeting CD86, CD206, or α-SMA, each at a dilution of 1:100, in BSA at different concentrations. The samples were incubated at 4°C for 12 hours. Following three washes with PBS, sections were treated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibodies. After rinsing, the slides were sealed, and images were collected for subsequent analysis. The proportion of positive cells was quantified using ImageJ software. Cytotoxicity Assay of MXene NIH-3T3 cells were plated at a density of 100,000 cells per well in a 24-well plate and incubated for 24 hours. Afterward, varying concentrations of the MXene solution were introduced into each well, and the cells were cocultured with 0, 100, 200, 300, or 400 μg/mL MXene for 24 hours. After that, the supernatant was removed, and the wells were rinsed three times with PBS. Afterward, a volume of 200 μL of the live/dead cell staining working solution was administered to each well and incubated for 30 minutes to facilitate staining, and pictures were taken using a fluorescence microscope. In vivo Biocompatibility Testing Eighteen male ICR mice, aged between 4 and 6 weeks, were procured and randomly assigned to six distinct groups. The administration protocol was conducted in accordance with the procedures established for diabetic wound treatment. The groups exposed to light received NIR irradiation (808 nm, 1 W/cm2) for 5 minutes right after the injection. On the fourteenth day, specimens were collected from the heart, liver, spleen, lung, kidney, and testis, and H&E staining was performed to analyze the histological morphology and pathological changes of each organ. Statistical Analysis Fluorescence intensity analysis, cell diameter measurement, bacterial plate cloning count, tube formation number analysis, wound area measurement, and tissue staining analysis were conducted using ImageJ software. Statistical analysis was performed using GraphPad Prism 10 software. Data derived from multiple experiments are presented as the mean ± standard deviation (SD); n = 3 (biological replicates). For comparisons between two specific groups, an unpaired two-tailed Student’s t-test was applied. For comparisons involving three or more groups, Levene’s test was first used to assess the homogeneity of variance. When the assumption of equal variances was met, one-way analysis of variance (ANOVA) was applied to evaluate the differences among the groups, and the Tukey multiple comparison method was further adopted for post-hoc multiple comparisons. P < 0.05 indicated statistically significant differences. Results and Discussion Synthesis and Characterization of MM To engineer MM, M2-type macrophages were first induced with IL-4 for 24 hours and subsequently cocultured with MXene nanosheets for an additional 24 hours. The cells were subsequently collected, redispersed in PBS, and immediately subjected to freeze-shock by immersion in liquid nitrogen for 24 hours. This rapid cryogenic treatment was designed to terminate cellular activity while minimizing the release of cytotoxic substances associated with continuous nanoparticle phagocytosis.25 Cell viability staining confirmed the efficacy of this process: while untreated, viable macrophages exhibited predominantly green fluorescence, the MM group showed intense red fluorescence, indicating near-complete loss of cell viability (Figure 1A and B). Compared with living cells, macrophage corpses not only avoid triggering immune rejection reactions at the wound site but also have significant advantages, such as low cost, easy storage, and convenient transportation. In addition, macrophage corpses can prevent MXene nanoparticles from being cleared by the body’s immune system.25,27 Characterization of MM. (A) Live/dead staining of live macrophages and MM (scale bar = 20 μm). (B) Ratio of live to dead cells in live macrophages and MM. (C) Phalloidin staining of live macrophages and MM (scale bar = 20 μm). (D) Diameter analysis of live macrophages and MM. (E) Coomassie Brilliant Blue analysis of protein content in live M2-type macrophages, M2, and MM. (F) WB analysis of proteins in live M2-type macrophages, M2, and MM. (G) SEM images of live M2-type macrophages and MM (scale bar = 2 μm). (H) TEM image of MM (scale bar = 100 nm). (I) Zeta potential of M2 and MM; data are presented as the mean ± SD, n = 3. (J) UV-Vis spectra of MXene solutions at different concentrations and MM. Morphologically, both viable macrophages and MM retained a complete cytoskeleton architecture, as visualized by green fluorescent phalloidin staining of microfilaments (Figure 1C). The cellular diameter for both groups was largely comparable, predominantly ranging from 10 to 12 μm (Figure 1D). Protein analysis via Coomassie Brilliant Blue staining demonstrated that the majority of the protein content present in viable M2 macrophages was preserved in both M2 macrophage corpses and MM (Figure 1E). Western blotting further confirmed the retention of key protein markers, including the anti-inflammatory cytokine TGF-β, the proinflammatory mediators TNF-α, IL-6, and IL-1β, and the macrophage marker F4/80 and CD206 (Figure 1F). These results indicate that the freeze-shock process preserves the structural and proteinaceous framework of cells. SEM revealed that MM maintained a spherical cellular morphology but displayed a surface topography that was considerably rougher than that of viable macrophages (Figure 1G). TEM provided critical insight into the internal structure of MM, revealing a distinct “shell-core” configuration. In this structure, the “shell” corresponds to the preserved cell membrane of the macrophage corpse, which encapsulates the “core” consisting of internalized MXene nanoparticles (Figure 1H). This biomimetic, cell membrane-coated architecture is anticipated to shield the MXene core from rapid recognition and elimination by the reticuloendothelial system. Physicochemical characterization revealed that MM exhibited good colloidal stability, with a Zeta potential of -10.00 ± 0.56 mV, similar to that of unloaded M2 macrophage corpses (-9.15 ± 0.57 mV) (Figure 1I). UV-Vis spectrophotometry analysis revealed that MM retained a high absorbance in the 200–300 nm range. While its spectrum was slightly shifted compared with that of pure MXene (which has a characteristic absorption peak at 285 nm), it followed a similar profile, corroborating the successful loading and encapsulation of MXene within the cellular scaffold (Figure 1J). Collectively, these data establish that the cryogenic shock-based engineering method successfully generates intact macrophage corpses loaded with MXene. This process preserves critical structural elements and protein components while rendering the cells nonviable. The resulting MM particles possess a biomimetic membrane coating, favorable dispersion stability, and optical properties of the encapsulated nanomaterial, laying a foundational platform for their subsequent application. Photothermal Performance of MM The photothermal conversion capability of MM was systematically evaluated using infrared thermographic imaging. Both MXene and MM demonstrated efficient photothermal performance under NIR irradiation at 808 nm with a power density of 1 W/cm2. The observed temperature increase clearly depended on the irradiation power at a fixed concentration (100 μg/mL). Upon exposure to NIR light at power densities of 0.5, 0.75, and 1.0 W/cm2, the solution temperatures reached 48.4, 60.1, and 63.2°C, respectively (Figure 2A). Similarly, under constant irradiation (1.0 W/cm2), the final temperature increased with increasing MXene concentration, reaching 60.2, 72.6, and 90.8°C at levels of 100, 200, and 300 μg/mL, respectively (Figure 2B). Photothermal performance of MM. (A) Curves of the increase in temperature of MXene under different irradiation powers. (B) Heat curves of MXene at different concentrations. (C) Infrared thermal images of MXene and MM under NIR (808 nm, 1 W/cm2). (D) Temperature curves of MXene and MM under NIR (808 nm, 1 W/cm2). (E) Temperature variation curves of MXene during five photothermal-cooling cycles. (F) Temperature variation curves of MM during five photothermal-cooling cycles. Under standardized conditions (1.0 W/cm2, 100 μg/mL), both MXene and MM suspensions showed a rapid temperature rise over time, plateauing at approximately 60°C and 54°C, respectively (Figure 2C–D). The marginally lower saturation temperature observed for MM is likely attributable to partial oxidation or material loss during the multi-step cell-based preparation process. Notably, both materials maintained stable photothermal performance across five consecutive laser on/off cycles, confirming excellent photothermal stability and reusability (Figure 2E–F). To assess the biocompatibility of the photothermal process, the viability of NIH-3T3 fibroblasts after exposure to photothermally treated MXene was quantified via live/dead fluorescence staining. The results indicated high cell viability (>92%) even at MXene concentrations as high as 400 μg/mL (Figure S3), confirming minimal acute photothermal cytotoxicity under the tested conditions. Studies have shown that a temperature of approximately 60°C does not damage surrounding normal tissues within a short period of time.33,34 Collectively, these data establish that MM retains the effective photothermal conversion properties of its MXene core while being packaged within a biomimetic cellular carrier. The concentration- and power-dependent heating profiles, coupled with robust cycling stability and favorable preliminary biocompatibility, underscore its potential as a controllable and efficient photothermal agent. In vitro Anti-Inflammatory Ability of MM Diabetic wounds are often accompanied by abnormal and persistent inflammatory responses. This chronic inflammatory microenvironment perpetuates oxidative stress, exacerbates tissue damage, and disrupts extracellular matrix remodeling, collectively contributing to impaired healing.35–39 The anti-inflammatory potential of MM was evaluated using an LPS-induced macrophage inflammation model, with gene expression analyzed by RT-qPCR. The levels of proinflammatory cytokines (IL-6 and CD80) were significantly upregulated in the LPS group, while the transcription of the anti-inflammatory factor (ARG-1) was markedly downregulated (Figure 3A–C). Compared with the LPS group, the mRNA abundance of proinflammatory factors (IL-6 and CD80) in the M2, MM, and MML groups was significantly lower, while the mRNA expression level of the anti-inflammatory factor (ARG-1) was significantly greater (Figure 3A–C). These findings indicate that M2, MM, and MML all have anti-inflammatory functions. This anti-inflammatory effect occurred because all these materials contained the corpse components of IL-4-induced M2 macrophages, which effectively alleviated the inflammatory response at the wound site. The timely resolution of inflammation was key to the transition of wound healing from the inflammatory to the proliferative stage. Detection of the in vitro anti-inflammatory activity of MM by RT-qPCR. (A) Relative mRNA expression level of IL-6. (B) Relative mRNA expression level of CD80. (C) Relative mRNA expression of ARG-1. **P < 0.01, ***P < 0.001, ****P < 0.0001 vs the LPS group; the data are shown as the mean ± SD; n = 3. In vitro Antioxidant Effects and Angiogenesis Ability of MM The overproduction of ROS and the consequent oxidative stress represent fundamental pathological characteristics that impair diabetic wound healing, causing cellular damage, suppressing collagen synthesis and angiogenesis, and perpetuating inflammation via pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).40,41 Consequently, antioxidant intervention is considered a critical therapeutic strategy.42 We evaluated the ROS-scavenging capacity of MM in vitro using a DCFH-DA probe. As illustrated in Figure 4A and B, a 12-hour exposure to H2O2 resulted in a significant elevation of intracellular ROS fluorescence in NIH-3T3 fibroblasts. While treatment with M2 macrophage corpses alone did not significantly alter ROS levels, both the MXene treatment and MM treatment resulted in a significant reduction in the fluorescence intensity. This confirms the intrinsic antioxidant activity of the MXene component. Notably, when combined with NIR, MXene and MM elicited an even greater decrease in ROS, suggesting a synergistic effect in which photothermal heating enhances oxidative stress mitigation. The exceptional antioxidant efficacy of MXene is primarily attributed to its unique physicochemical properties, including a layered structure and abundant surface functional groups (eg, -OH and -O), which facilitate ROS elimination through combined physicochemical mechanisms. The photothermal effect likely augments this activity by accelerating surface electron transfer and improving nanomaterial–cell interactions, thereby promoting more efficient radical scavenging.43 In vitro antioxidant effects and angiogenesis ability of MM. (A) ROS fluorescence images of NIH-3T3 cells after various treatments (scale = 50 μm). (B) Quantification of ROS fluorescence intensity. **P < 0.01, ****P < 0.0001; the data are shown as the mean ± SD (n = 3). (C) Representative images of tube formation (scale = 100 μm). (D) Quantitative analysis of the number of junctions. (E) Quantitative analysis of the number of branches. ***P < 0.001, ****P < 0.0001; the data are shown as the mean ± SD (n = 3). Adequate angiogenesis is fundamental to diabetic wound repair, as it restores oxygen and nutrient supply, modulates inflammation, and supports tissue remodeling.44–46 We assessed the ability of MM to promote angiogenesis using a capillary-like structure formation assay on matrigel with HUVECs. After 3 hours, the cells in the Control group displayed sparse tube formation. Conversely, all treatment groups—M2, M, and ML—demonstrated significant increases in network parameters, including junction numbers and branch points. Importantly, the MM and MML groups outperformed all the others, yielding more extensive, complete, and continuous tubular networks (Figure 4C–E). These results indicate that MM not only preserves but also enhances the pro-angiogenic activity associated with its cellular carrier, highlighting its dual function in modulating oxidative stress and promoting vascularization. Antibacterial Properties of MM Diabetic wounds are highly susceptible to bacterial infection, which is a major complication that impedes healing and can lead to severe outcomes such as amputation.47,48 This vulnerability stems from a hyperglycemic microenvironment that fuels bacterial proliferation and biofilm formation while concurrently impairing host immune responses.47,48 Coupled with the rising challenge of antibiotic resistance, there is a clear demand for alternative antibacterial strategies.49,50 We therefore evaluated the antibacterial efficacy of MM against representative Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria. As illustrated in Figure 5A–D, the Control groups (medium alone) and those containing only M2 macrophage corpses showed no significant reduction in bacterial colonies, with or without NIR irradiation. In contrast, treatment with MXene or MM alone (without light) resulted in a significant decrease in colony-forming units for both bacterial strains, indicating an intrinsic antibacterial property. This baseline activity is consistent with reports in the literature that attributed the inherent bactericidal effect of MXene to its sharp, two-dimensional nanosheet structure, which can physically disrupt bacterial cell membranes and induce cytoplasmic leakage.51,52 Antibacterial properties of MM. (A) Colony formation pictures of the antibacterial effect of MM on E. coli. (B) Colony formation pictures of the antibacterial effect of MM on S. aureus. (C) Plate colony counts of E. coli. (D) Plate colony counts of S. aureus. ns P > 0.05, ****P < 0.0001; the data are shown as the mean ± SD (n = 3). Notably, upon NIR irradiation, the antibacterial effect of both MXene and MM was significantly enhanced, resulting in a further reduction in viable bacterial counts (Figure 5A–D). This photothermal synergy suggests a dual-mode antibacterial mechanism. Primarily, light-independent interactions involve direct nanomaterial-membrane interactions.51,52 The secondary, NIR-triggered effect is likely mediated by localized hyperthermia, which can denature microbial proteins and nucleic acids, thereby complementing and amplifying the initial physicochemical damage.53 Importantly, MM retained this enhanced activity, demonstrating that the encapsulation process did not compromise the photothermal or membrane-disruptive functions of the MXene core. MM Promotes Diabetic Wound Healing The therapeutic efficacy of MM was assessed in an STZ-induced diabetic ICR mouse model. First, mice with stable hyperglycemia (glycemia ≥ 16.7 mmol/L) were enrolled (the changes of mice weight and water intake within 14 days are shown in Figure S4). A uniform full-thickness excisional wound (6 mm in diameter) was subsequently induced on the dorsum of each mouse. The mice were subsequently randomized into six groups (n = 3): PBS group (Control), M2, MXene (M), MXene with NIR irradiation (ML), MM, and MM with NIR irradiation (MML). Wound closure was monitored and quantified over time. Figure 6A–C illustrate a gradual decrease in the extent of wounds across groups throughout the duration of the experiment. The wound healing rates across the groups show a discernible trend: the Control group shows the slowest healing, whereas the groups receiving M2, M, ML, MM, and MML treatments exhibit sequentially improved rates of closure. Wound repair in diabetic mice. (A) Representative photographs of wound healing in each group at the indicated time points (size: 1 cm × 1 cm). (B) Schematic illustration of wound repair (size: 1 cm × 1 cm). (C) Wound closure rates for each group over time. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; the data are shown as the mean ± SD (n = 3). The in vivo wound closure trend is generally consistent with the multifunctional in vitro profile of MM. The observed therapeutic benefit likely arises from a combination of factors, including the intrinsic photothermal antibacterial and antioxidant activities of the MXene core, coupled with the preserved biological matrix of the macrophage corpse. These factors may collectively help modulate the wound microenvironment. Given the bioactive nature of this composite, assessing its biocompatibility was crucial. Therefore, a preliminary safety evaluation was conducted in healthy mice to investigate the potential systemic or local toxicity associated with MM administration. The results indicate no significant adverse effects at the tested dose (Figure S5), supporting a favorable initial safety profile for its topical application. H&E and Masson Staining Analysis To conduct a more thorough assessment of new tissue formation and the healing process at the wound site, we employed H&E staining and Masson staining techniques on skin samples from diabetic wounds. Through these staining methods, the histological characteristics of each group in terms of wound length and collagen deposition could be systematically observed. As shown in Figure 7A and B, significant variations in wound length are detected among the various experimental groups on the sixth day of treatment. Compared with the Control group, the wound lengths in all the treatment groups significantly decrease, with the MML group showing the most significant wound contraction; by the 12th day, the wound lengths in all the groups further decrease. Histological analysis of wounds in treated diabetic mice. (A) Typical H&E-stained wound sections in diabetic mice on days 6 and 12 post-treatment (the black arrow indicates the boundary between the wound and normal tissue; scale = 1 mm). (B) Representative Masson staining images of wounds in diabetic mice on days 6 and 12 post-treatment (scale = 1 mm). (C) Wound length quantification in mice on days 6 and 12 post-treatment. (D) Collagen content quantification in mice on days 6 and 12 post-treatment. *P < 0.05, **P < 0.01, ****P < 0.0001; the data are shown as the mean ± SD (n = 3). Collagen deposition is one of the crucial indicators for evaluating wound healing quality, as it is a key determinant of wound tensile strength and orderly tissue remodeling. During wound repair, fibroblasts continuously synthesize and secrete collagen, and the secreted collagen molecules gradually aggregate in the extracellular matrix to form collagen fibrils, which further assemble into mature collagen fiber bundles. Adequate and ordered collagen deposition is essential for restoring the mechanical properties of damaged skin: mature collagen fiber accumulation effectively improves wound tensile strength, prevents wound dehiscence, and guides physiological tissue remodeling, which avoids excessive scar formation and promotes the reconstruction of normal skin tissue structure and function.54 In Masson staining, collagen fibers are specifically stained blue. On the sixth day, minimal collagen deposition is noted in both the Control and M2 groups, whereas the MM group and MML group show more obvious collagen production, with the collagen deposition rate in the MML group reaching 38.73% ± 1.08%. By the 12th day, compared with that on the 6th day, the amount of collagen deposition in all the groups has increased. In comparison with the Control group, collagen deposition in the M2 and M groups does not exhibit a marked increase. However, a notable increase in collagen deposition is observed in the ML, MM, and MML groups, with the MML group reaching a level of 73.14% ± 1.49% (Figure 7C and D). At different time points, the MML group consistently exhibits the greatest degree of collagen deposition, suggesting that it has the best effect on wound healing. These findings indicate that this treatment method can more effectively promote collagen generation and accumulation, thereby hastening wound resolution. Immunohistochemical Staining Analysis Immunohistochemical analysis of wound tissues harvested on day 6 provided further insight into the therapeutic mechanisms of MM. The inflammatory status and vascularization within the wound area were evaluated through key protein expression patterns. Inflammatory status, a key determinant of healing progression, was assessed by examining the expression of CD86 (associated with proinflammatory activation) and CD206 (linked to the resolution of inflammation). Compared with the Control group, the groups treated with M2 macrophage corpses, MM, and MML substantially reduced the presence of CD86 while increasing the level of CD206 (Figure 8A–C). This shift in the expression profile reflects measurable attenuation of the local inflammatory response, aligning with and further validating the anti-inflammatory functionality demonstrated in vitro. Immunohistochemical analysis of wounds in diabetic mice treated with MM. (A) Immunohistochemical staining images of diabetic mice 6 days after treatment (scale = 100 μm). (B) CD86 expression quantification. (C) CD206 expression quantification. (D) α-SMA expression quantification. ****P < 0.0001; the data are shown as the mean ± SD (n = 3). Angiogenesis, an essential process for providing oxygenation and nutritional support to injured sites, was evaluated by staining for α‑smooth muscle actin (α‑SMA). In comparison with the Control group, the abundance of α‑SMA was elevated in the M2, M, ML, MM, and MML groups, with MM and MML showing the most pronounced effects (Figure 8A and D). These findings suggest enhanced vascular maturation and stability within the granulation tissue. The proangiogenic effect may result from a combination of factors such as biological cues retained by M2 macrophage corpses, which can recruit and support endothelial cells, and the antioxidant activity of MXene, which alleviates oxidative stress.55–57 The trend toward greater improvement in the MM and MML groups indicates a potential synergistic contribution from the composite material (Figure 8A and D). Conclusion In this study, we successfully fabricated a biomimetic nanocomposite (MM) by encapsulating MXene within freeze-killed M2 macrophages. MM retained the structure and functional proteins of M2 macrophages, exhibited excellent photothermal properties, and demonstrated potent combined effects in alleviating inflammation, scavenging ROS, eradicating bacteria (particularly under NIR irradiation), and promoting angiogenesis in vitro. The resulting MM is easy to synthesize. It possesses favorable biocompatibility under the current experimental conditions. It can simultaneously achieve anti-inflammatory, antioxidant, antibacterial, and pro-angiogenic functions. Most importantly, in a diabetic mouse wound model, MM, especially when combined with NIR irradiation (MML), significantly accelerated wound closure, enhanced collagen deposition, and favorably modulated the wound microenvironment, outperforming control and single-component treatments. This work presents a novel strategy using macrophage corpses as multifunctional carriers for nanotherapeutics, effectively integrating drug delivery, anti-inflammation, and photothermal-enhanced therapy to address the complex challenges associated with diabetic wound healing. The MM platform holds significant promise as a versatile and efficacious strategy for the treatment of chronic diabetic wounds and warrants further investigation for clinical translation, including the long-term in vivo biosafety and degradation characteristics of MM, the potential immunogenicity after repeated administration of freeze-killed M2 macrophage-derived components, the optimal dose and treatment regimen, the therapeutic efficacy in more severe or infected wound models, the validation in large animal models such as pigs, and the scalability and batch-to-batch consistency of MM production. Funding Statement This research was supported by the National Natural Science Foundation of China (82573571), the Shanghai 2025 Basic Research Plan Natural Science Foundation (25ZR1401393), the Key Project of Heilongjiang Provincial Joint Fund of Natural Science Foundation (ZL2025H017), the First Batch of Open Topics of the Shanghai Key Laboratory of Nautical Medicine and Translation of Drugs and Medical Devices (2025QN13), and the Basic Scientific Research Project of University belonging to Heilongjiang (2023-KYYWF-0923, 2024-KYYWF-0469). Disclosure The authors report no conflicts of interest in this work. References